- Dec 28, 2018
Promising drug for pediatric leukemia in developing stages
Scientists from Northwestern Medicine have found that if they could stabilize the MLL protein -- the one responsible for the spread of the disease -- they could work to slow down the progression of leukemia in affected patients. Read more: https://www.consumeraffairs.com/news/promising-drug-for-pediatric-leukemia-in-developing-stages-122718.html
- Dec 28, 2018
Research reveals machinery of a deadly childhood brain cancer
St. Jude Children's Research Hospital scientists have mapped the effects of aberrant biological machinery that drives a deadly brain cancer called diffuse intrinsic pontine glioma (DIPG). Read more: https://medicalxpress.com/news/2018-12-reveals-machinery-deadly-childhood-brain.html
- Dec 17, 2018
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of solid tumors many years later. Read more: https://medicalxpress.com/news/2018-12-survivors-childhood-hodgkin-lymphoma-high.html
- Dec 17, 2018
Childhood leukaemia medical breakthrough to help sufferers
A major breakthrough by researchers in Sydney has opened up the possibility for new and better treatments for ALL, the most common childhood cancer. Read more: https://www.dailytelegraph.com.au/news/nsw/childhood-leukaemia-medical-breakthrough-to-help-sufferers/news-story/c0442b7bc2cdb9ad5b8a028d668fb562
- Dec 14, 2018
Predictions of early responses in paediatric acute lymphoblastic leukaemia
Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair. Read more: https://www.europeanpharmaceuticalreview.com/news/82268/paediatric-all/
- Dec 6, 2018
'Chemo brain' caused by malfunction in three types of brain cells, study finds
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists at the Stanford University School of Medicine have demonstrated that a widely used chemotherapy drug, methotrexate, causes a complex set of problems in three major cell types within the brain's white matter. Read more: https://medicalxpress.com/news/2
- Dec 5, 2018
Imaging protocol assesses molecular mechanism in the treatment of deadly childhood cancer
In collaboration with researchers from the Children's Cancer Institute (CCI) in Sydney, imaging was pivotal in understanding the mechanism of a promising new treatment developed at CCI for the childhood cancer neuroblastoma. Read more: https://medicalxpress.com/news/2018-12-imaging-protocol-molecular-mechanism-treatment.html